Taconic Biosciences prioritizes accessibility and efficiency in preclinical research. Unlike other providers, Taconic does ...

Researchers suggest results could reignite interest in DLK inhibition as a treatment strategy for neurodegenerative diseases.

Results showed that FGFR2 gene deletion led to significantly fewer precancerous lesions and delayed PDAC tumor formation ...

Drug developers will now have enhanced abilities to rapidly prototype, test, iterate, and scale up their mRNA therapeutics.

Sponsored content brought to you by NGS continually delivers breakthroughs in genomics, and to do so, it relies on the crucial step of sample preparation. Complex and expensive workflows are ...

Mapping an antibody’s epitope, where it binds a target, can now be done in three dimensions, which optimizes the selection of application-specific antibodies.